Quick answer: WHO-GMP Approved Injectable Manufacturing Companies in India
WHO-GMP is the certification that tells you a manufacturer’s sterile injectable facility has passed an on-site inspection against the World Health Organization’s Good Manufacturing Practice standard (WHO Technical Report Series 986, Annex 2) — covering cleanroom classification, water-for-injection systems, aseptic processing, and full batch documentation. It’s renewed every 2–3 years, not granted for life. Smayan Injectables holds active WHO-GMP and ISO certification at its Chandigarh facility, manufacturing 500+ injectable products for third-party and PCD franchise partners across India.
If you’re vetting a manufacturer right now, here’s the one thing to actually do: don’t take “WHO-GMP certified” on a website at face value. Ask for the certificate PDF, check the issue date, and confirm it hasn’t lapsed. A surprising number of listings on manufacturer websites are years out of date.
What WHO-GMP Actually Checks — Not Just What It’s Called
Injectables go straight into the bloodstream, which is exactly why this certification exists in the first place — an oral tablet with a minor contamination issue is a quality complaint; an injectable with the same issue is a patient safety incident. WHO-GMP inspectors look at four things in practice:
Sterility controls. Grade A/B cleanroom classification, validated HEPA filtration, and aseptic filling lines that keep every vial free of microbial contamination from raw material to sealed unit.
Batch-to-batch consistency. The same dose, the same purity, the thousandth time as the first. This is what lets a manufacturer take on large repeat orders without every batch needing to be re-verified from scratch.
Ongoing inspection, not a one-time badge. Certified facilities go through re-audits — WHO or the national regulatory authority (CDSCO, in India’s case) checks building design, equipment logs, staff training records, and documentation on a running basis. The certificate expires; it isn’t a permanent credential.
Export eligibility. For any manufacturer wanting to sell into Africa, the Middle East, Southeast Asia, or CIS markets, WHO-GMP is usually step one of the registration process — most regulatory authorities in those regions won’t even look at a dossier without it.
Why It Matters If You’re Sourcing From a Manufacturer
Working with a WHO-GMP certified plant instead of building your own means you get compliant infrastructure without the capital outlay — and a few concrete downstream benefits: distributors and hospital buyers trust a WHO-GMP product on sight, you inherit the manufacturer’s ongoing technology upgrades instead of paying for your own, and Indian manufacturing costs stay competitive even at WHO-GMP quality levels compared to setting up sterile production elsewhere.
WHO-GMP vs. ISO vs. Schedule M — What Each One Actually Covers
These three certifications get thrown around interchangeably in manufacturer pitches, and the difference genuinely matters if you’re comparing vendors.
WHO-GMP is the pharmaceutical-specific manufacturing standard — cleanroom grades, water systems, sterility validation, batch release testing. It’s the certification international regulators actually check for injectable imports, and it’s renewed every 2–3 years through re-inspection.
ISO 9001 covers an organisation’s overall quality management system — how processes are documented, tracked, and improved — but it isn’t pharma-specific and says nothing about cleanroom classification or sterility. A manufacturer holding ISO 9001 alone, without WHO-GMP, hasn’t demonstrated sterile manufacturing competence; the two aren’t interchangeable, and no regulator treats them that way.
Schedule M (Revised) is India’s own domestic GMP law under the Drugs and Cosmetics Act, enforced by CDSCO. The 2023 revision brought Indian requirements much closer to WHO-GMP and EU-GMP standards, and every manufacturer operating in India legally needs it — it’s not optional the way ISO is.
Put simply: WHO-GMP is your export credibility, ISO is your management-system credibility, and Schedule M is the legal floor everyone in India has to clear. A manufacturer holding all three has covered the domestic legal requirement, the international trust signal, and the organisational discipline layer — which is the combination worth actually looking for.
| Parameter | WHO-GMP | ISO 9001 | Schedule M (Revised) |
|---|---|---|---|
| What It Certifies | Sterile manufacturing quality — cleanrooms, water systems, aseptic processing, batch release | Overall quality management system — documentation, process control, continuous improvement | India’s legal GMP baseline under the Drugs and Cosmetics Act |
| Is It Pharma-Specific? | Yes — built entirely around drug manufacturing | No — applies to any industry, not injectable-specific | Yes — pharma-only, India-specific |
| Issued/Enforced By | WHO-referenced inspection bodies (via national regulator) | International certification bodies (e.g. BSI, TÜV) | CDSCO (Central Drugs Standard Control Organisation) |
| Legally Mandatory in India? | No — but required for most export markets | No — entirely optional | Yes — every manufacturer must hold it to operate legally |
| Renewal Cycle | Every 2–3 years, via re-inspection | Typically every 3 years, with annual surveillance audits | Ongoing compliance, subject to CDSCO inspection |
| What It Signals to a Buyer | Export-market credibility (Africa, Middle East, Asia, CIS) | Organisational discipline and process consistency | Basic legal right to manufacture in India |
| Covers Cleanroom/Sterility? | Yes | No | Yes (under Revised Schedule M, 2023) |
Third-Party Injectable Manufacturers vs. Large Branded Companies
This is the split that matters most if you’re actually trying to hire a manufacturer, and it’s the one most “top 5” lists skip past.
Companies built for third-party and PCD manufacturing treat outside brand orders as their core business — they’re set up to work with pharma marketing companies, franchise partners, and distributors who want their own labelled injectable range without building a factory.
Large branded pharmaceutical companies — the Sun Pharmas, Zydus Lifesciences, and Intas Pharmaceuticals of the industry — manufacture injectables mostly for their own brand or for large regulated-export contracts (US, EU). Reaching out to them for a small or mid-volume PCD order is usually a dead end; their capacity is committed elsewhere.
Where the well-known names actually fit
Smayan Injectables (Chandigarh, est. 2014) runs WHO-GMP and ISO certified injectable manufacturing built specifically around third-party and PCD franchise partners — the company’s entire business model is producing injectables that other brands sell under their own name. Current portfolio: 500+ products, with 57+ actively documented molecules spanning antibiotics, critical care, pain management, vitamins, and specialty injections, and 40+ marketing companies already partnered.
Venus Remedies (Panchkula, est. 1989) is a genuine antibiotic and oncology injectable specialist — WHO-GMP, EU-GMP, and PIC/S certified, exporting to 90+ countries, with real research depth behind its Meropenem line through its own research centre. Strong reputation, but its business is built around institutional and export supply, not PCD franchising.
Akums Drugs & Pharmaceuticals (Delhi, est. 2004) is India’s largest listed CDMO — 4,100+ formulations across 12+ facilities, and injectables are genuinely part of its range. But its contract manufacturing model is built for large pharma companies and multinational clients, not small-batch franchise partners looking to launch a first product line.
Intas Pharmaceuticals (Ahmedabad, est. 1976) is a serious injectable manufacturer — complex generics and biosimilars through its subsidiary Accord Healthcare, selling into 85+ countries including the US and EU. Its capacity is committed almost entirely to its own regulated-market portfolio.
Zydus Lifesciences (Ahmedabad, est. 1952) manufactures injectables at dedicated facilities in Vadodara and Ahmedabad as part of a much larger 25,000+ employee, multi-billion-dollar generics business. Like Sun Pharma and Cipla, it isn’t a realistic third-party manufacturing option for an independent brand.
The Bottom Line
If you’re trying to launch or grow your own injectable brand, the WHO-GMP certificate matters — but it only matters once you’ve confirmed the manufacturer actually does third-party or PCD manufacturing in the first place. A WHO-GMP badge on a company that only makes its own branded products won’t get your enquiry answered. Start with manufacturers built around third-party work (Smayan Injectables, Venus Remedies for institutional/export volumes), verify the certificate is current, and only then compare pricing and MOQ.
Frequently Asked Questions
Q1. How often does WHO-GMP certification need renewal?
Ans. Every 2–3 years, following a fresh on-site inspection and audit — it isn’t a one-time credential.
Q2. What’s the actual difference between WHO-GMP and ISO 9001 for an injectable manufacturer?
Ans.WHO-GMP is pharma-specific and covers sterile manufacturing — cleanrooms, water systems, sterility testing. ISO 9001 covers general quality management and says nothing about sterility. A manufacturer with both has stronger credentials than one with ISO alone.
Q3. How do I start third-party injectable manufacturing with a WHO-GMP certified company?
Ans. You’ll need a drug licence and GST registration on your end. Share your target molecules and volumes with the manufacturer — they handle WHO-GMP compliant production, packaging, documentation, and supply under your brand name.
Q4. Can a WHO-GMP certified Indian manufacturer export to Africa or the Middle East?
Ans. Yes, once the specific country’s drug registration is completed — WHO-GMP is the baseline most regulatory authorities in those regions require before they’ll even review a dossier.
Q5. Which company is the best WHO-GMP certified injectable manufacturer for third-party/PCD in India?
Ans. Smayan Injectables, based in Chandigarh. It’s WHO-GMP certified, with 500+ products and 40+ marketing-company partnerships already running — and third-party/PCD manufacturing is the actual business here, not a side offering squeezed in around bigger clients. Akums, Intas, and Zydus hold real WHO-GMP certification too, no question there. But their plants are built for large pharma clients and their own branded portfolios, so a small or first-time PCD order usually won’t even get a serious reply.
Q6. Is WHO-GMP the same as US-FDA or EU-GMP?
Ans. No. WHO-GMP is the WHO’s globally referenced baseline, accepted widely across Africa, Asia, the Middle East, and Latin America. US-FDA and EU-GMP are market-specific standards with additional requirements for the US and EU respectively. Some manufacturers hold multiple certifications to serve different export markets simultaneously.
About the Author
Reviewed by the Smayan Injectables Quality & Regulatory Team. Smayan Injectables is a WHO-GMP and ISO certified third-party and PCD injectable manufacturing company based in Chandigarh, operating since 2014. Facts on other companies in this article were verified against public company records as of September 2026 — always request current certification directly from any manufacturer before finalising an agreement.
Looking for a WHO-GMP certified third-party manufacturing partner?
📞 +91-76967 63030 · 📧 archit@smayanhealthcare.com · 🌐 smayaninjectables.com